432 related articles for article (PubMed ID: 7522807)
21. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
[TBL] [Abstract][Full Text] [Related]
22. Human parvovirus B19 infection in children: uncommon clinical presentations.
Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y
Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
[TBL] [Abstract][Full Text] [Related]
23. [Cardiac involvement in fetal parvovirus B19 infection].
Soulié JC
Pathol Biol (Paris); 1995 May; 43(5):416-9. PubMed ID: 8532380
[TBL] [Abstract][Full Text] [Related]
24. [Parvovirus B19 in the Czech Republic. Seroepidemiologic study].
Sodja I; Mrázová M; Smelhausová M; Sámal J
Epidemiol Mikrobiol Imunol; 1997 Mar; 46(1):23-6. PubMed ID: 9162451
[TBL] [Abstract][Full Text] [Related]
25. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.
Matsuda H; Sakaguchi K; Shibasaki T; Takahashi H; Kawakami Y; Furuya K
J Perinat Med; 2005; 33(6):561-3. PubMed ID: 16318623
[TBL] [Abstract][Full Text] [Related]
26. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
27. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
Ziyaeyan M; Rasouli M; Alborzi A
Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
[TBL] [Abstract][Full Text] [Related]
28. [Parvovirus B19 infection and pregnancy].
Savey L; Poissonnier MH; Leblanc M; Colau JC
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(2):170-6. PubMed ID: 7782589
[TBL] [Abstract][Full Text] [Related]
29. Parvovirus B19 in pregnancy.
Ergaz Z; Ornoy A
Reprod Toxicol; 2006 May; 21(4):421-35. PubMed ID: 16580942
[TBL] [Abstract][Full Text] [Related]
30. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome.
Gratacós E; Torres PJ; Vidal J; Antolín E; Costa J; Jiménez de Anta MT; Cararach V; Alonso PL; Fortuny A
J Infect Dis; 1995 May; 171(5):1360-3. PubMed ID: 7751717
[TBL] [Abstract][Full Text] [Related]
31. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
Bdour S
Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
[TBL] [Abstract][Full Text] [Related]
32. Fifth disease in a small rural community. What are the consequences?
Kelly HA; Rae PB; Donnelly JK; Leydon JA
Aust Fam Physician; 1999 Feb; 28(2):139-44. PubMed ID: 10048252
[TBL] [Abstract][Full Text] [Related]
33. [Parvovirus B19 infection--an insidious chameleon].
Broliden K; Tolfvenstam T; Papadogiannakis N; Westgren M; Matt P; Lundqvist A; Skjöldebrand-Sparre L; Nyman M; Henter JI
Lakartidningen; 1999 Nov; 96(46):5066-9. PubMed ID: 10608130
[TBL] [Abstract][Full Text] [Related]
34. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.
Guidozzi F; Ballot D; Rothberg AD
J Reprod Med; 1994 Jan; 39(1):36-8. PubMed ID: 8169914
[TBL] [Abstract][Full Text] [Related]
35. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
Oliveira SA; Camacho LA; Pereira AC; Faillace TF; Setubal S; Nascimento JP
Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):965-70. PubMed ID: 12471422
[TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
37. [Parvovirus B19 infections. The cause of fifth disease-erythema infectiosum--can also cause aplastic crises, fetal damage and polyarthritis].
Hornsleth A; Carlsen KM
Ugeskr Laeger; 1990 May; 152(19):1354-7. PubMed ID: 2160748
[TBL] [Abstract][Full Text] [Related]
38. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
39. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
